In non-small cell lung cancer (NSCLC), two key genetic alterations, epidermal growth factor receptor (<i>EGFR</i>) mutations and anaplastic lymphoma kinase (<i>ALK</i>) rearrangements, are commonly believed to be mutually exclusive. This evidence concerns the gene ALK and non-small cell lung carcinoma.